- Aug 2024
-
-
the first question that came in and as we're embracing remote and hybrid working as The New Normal how do you address this from a neuroscience perspective
for - question - neuroscience - efficacy of hybrid remote and live work environments
-
in fact the best ideas happen when you are not planning them when you are just creating an environment where people get together in an informal way this is the reason why um Steve Jobs when he designed the Pixar building um he the initial idea was there's just one bathroom for the whole company
for - neuroscience - building design - common area to converge everyone - creates diverse social meetings - increases work efficacy - example - Steve Jobs - Pixar bathroom
-
upport cross-divisional thinking and that the best ideas are already in a company and it's just a matter of sort of um getting people together
for - neuroscience - validation for Stop Reset Go open source participatory system mapping for design innovation
neuroscience - validation for Stop Reset Go open source participatory system mapping for design innovation - bottom-up collective design efficacy - What Henning Beck validates for companies can also apply to using Stop Reset Go participatory system mapping within an open space to de-silo and be as inclusive as possible of many different silo'd transition actors
-
by doubling the size of the tables in the in the eating in the eating areas they increase cross-divisional across talk um in a very informal way they found out that cross-department um Corporation increased after that and the and the code and the code output increased two months later
for - neuroscience - example - informal diversity - increases work efficacy - via sharing diverse and novel perspectives
-
catching a break is necessary in order to refill your mental capacities and as a rule of thumb you can say that it's it's five to one five parts of work one part of doing a break so 50 minutes working 10 minutes catching a break
for - neuroscience - efficient work - relaxation rule
neuroscience - efficient work - relaxation rule - It is necessary to build NO WORK time into effective work - 5 time units work - 1 time unit relaxation - It is necessary to step back from concentrating on a problem - for the brain to drift away from it and - relax from concentrating on the problem - so that new perspectives can develop that can be brought back to solve the problem
Tags
- question - neuroscience - efficacy of hybrid remote and live work environments
- neuroscience - efficient work - relaxation rule
- neuroscience - problem solving efficacy - no work periods are required
- neuroscience - validation for Stop Reset Go open source participatory system mapping for design innovation - bottom-up collective design efficacy
- neuroscience - building design - common area to converge everyone - creates diverse social meetings - increases work efficacy - example - Steve Jobs - Pixar bathroom
- neuroscience - example - informal diversity - increases work efficacy - via sharing diverse and novel perspectives
Annotators
URL
-
- Jan 2024
-
rpdesk-docdel.s3-us-west-2.amazonaws.com rpdesk-docdel.s3-us-west-2.amazonaws.com
- Aug 2022
-
www.medrxiv.org www.medrxiv.org
-
Gilbert, P. B., Montefiori, D. C., McDermott, A., Fong, Y., Benkeser, D. C., Deng, W., Zhou, H., Houchens, C. R., Martins, K., Jayashankar, L., Castellino, F., Flach, B., Lin, B. C., O’Connell, S., McDanal, C., Eaton, A., Sarzotti-Kelsoe, M., Lu, Y., Yu, C., … Teams, U. S. G. (USG)/CoVPN B. (2021). Immune Correlates Analysis of the mRNA-1273 COVID-19 Vaccine Efficacy Trial. MedRxiv, 2021.08.09.21261290. https://doi.org/10.1101/2021.08.09.21261290
-
-
www.theguardian.com www.theguardian.com
-
Willsher, K. (2021, October 11). French study of over 22m people finds vaccines cut severe Covid risk by 90%. The Guardian. https://www.theguardian.com/world/2021/oct/11/french-study-vaccines-cut-covid-deaths
-
-
osf.io osf.io
-
Mulot, M., Segalas, C., Leyrat, C., & Besançon, L. (2021). Vaccination rates and COVID-19 cases: A commentary of “Increases in COVID-19 are unrelated to levels of vaccination across 68 countries and 2947 counties in the United States.” OSF Preprints. https://doi.org/10.31219/osf.io/72abp
-
-
www.nature.com www.nature.com
-
Pozzetto, B., Legros, V., Djebali, S., Barateau, V., Guibert, N., Villard, M., Peyrot, L., Allatif, O., Fassier, J.-B., Massardier-Pilonchéry, A., Brengel-Pesce, K., Yaugel-Novoa, M., Denolly, S., Boson, B., Bourlet, T., Bal, A., Valette, M., Andrieu, T., Lina, B., … Trouillet-Assant, S. (2021). Immunogenicity and efficacy of heterologous ChadOx1/BNT162b2 vaccination. Nature, 1–9. https://doi.org/10.1038/s41586-021-04120-y
-
-
www.nature.com www.nature.com
-
Gebre, M. S., Rauch, S., Roth, N., Yu, J., Chandrashekar, A., Mercado, N. B., He, X., Liu, J., McMahan, K., Martinot, A., Martinez, D. R., Giffin, T., Hope, D., Patel, S., Sellers, D., Sanborn, O., Barrett, J., Liu, X., Cole, A. C., … Barouch, D. H. (2021). Optimization of Non-Coding Regions for a Non-Modified mRNA COVID-19 Vaccine. Nature, 1–8. https://doi.org/10.1038/s41586-021-04231-6
-
-
www.biorxiv.org www.biorxiv.org
-
Iketani, S., Liu, L., Guo, Y., Liu, L., Huang, Y., Wang, M., Luo, Y., Yu, J., Yin, M. T., Sobieszczyk, M. E., Huang, Y., Wang, H. H., Sheng, Z., & Ho, D. D. (2022). Antibody Evasion Properties of SARS-CoV-2 Omicron Sublineages (p. 2022.02.07.479306). bioRxiv. https://doi.org/10.1101/2022.02.07.479306
-
-
www.nytimes.com www.nytimes.com
-
Zimmer, C. (2021, September 21). An extra J. & J. shot substantially boosts protection against Covid, the company reports. The New York Times. https://www.nytimes.com/2021/09/21/health/johnson-and-johnson-shot.html
-
-
twitter.com twitter.com
-
Dowdy, D. (2021, September 21). On the J&J booster news, keep in mind: 1. Median follow-up since 2nd dose was just 36 days, 2. Efficacy vs moderate COVID was 75% globally, and 3. Total number of cases in the US was 15. Please don’t take this to mean that a 2nd dose provides long-term increase in protection. Https://t.co/RnqDNBmwuD [Tweet]. @davidwdowdy. https://twitter.com/davidwdowdy/status/1440323242942554122
-
-
demtech.oii.ox.ac.uk demtech.oii.ox.ac.uk
-
DemTech | COVID-19 Misinformation Newsletter 24 August 2021. (2021, August 24). https://demtech.oii.ox.ac.uk/covid-19-misinformation-newsletter-24-august-2021/#continue
-
-
inst-fs-iad-prod.inscloudgate.net inst-fs-iad-prod.inscloudgate.net
-
Krause, P. R., Fleming, T. R., Peto, R., Longini, I. M., Figueroa, J. P., Sterne, J. A. C., Cravioto, A., Rees, H., Higgins, J. P. T., Boutron, I., Pan, H., Gruber, M. F., Arora, N., Kazi, F., Gaspar, R., Swaminathan, S., Ryan, M. J., & Henao-Restrepo, A.-M. (2021). Considerations in boosting COVID-19 vaccine immune responses. The Lancet, 4. https://doi.org/10.1016/S0140-6736(21)02046-8
Tags
- lang:en
- politics
- Delta variant
- vaccine efficacy
- vaccine
- is:article
- booster
- immune response
- COVID-19
- immunity
- science
Annotators
URL
-
-
www.medrxiv.org www.medrxiv.org
-
Regev-Yochay, G., Gonen, T., Gilboa, M., Mandelboim, M., Indenbaum, V., Amit, S., Meltzer, L., Asraf, K., Cohen, C., Fluss, R., Biber, A., Nemet, I., Kliker, L., Joseph, G., Doolman, R., Mendelson, E., Freedman, L. S., Harats, D., Kreiss, Y., & Lustig, Y. (2022). 4th Dose COVID mRNA Vaccines’ Immunogenicity & Efficacy Against Omicron VOC (p. 2022.02.15.22270948). medRxiv. https://doi.org/10.1101/2022.02.15.22270948
-
-
www.nature.com www.nature.com
-
Meng, B., Abdullahi, A., Ferreira, I. A. T. M., Goonawardane, N., Saito, A., Kimura, I., Yamasoba, D., Gerber, P. P., Fatihi, S., Rathore, S., Zepeda, S. K., Papa, G., Kemp, S. A., Ikeda, T., Toyoda, M., Tan, T. S., Kuramochi, J., Mitsunaga, S., Ueno, T., … Gupta, R. K. (2022). Altered TMPRSS2 usage by SARS-CoV-2 Omicron impacts tropism and fusogenicity. Nature, 1–1. https://doi.org/10.1038/s41586-022-04474-x
-
-
psyarxiv.com psyarxiv.com
-
Ozernov-Palchik, O., Olson, H., Arechiga, X., Kentala, H., Solorio-Fielder1, J. L., Wang, K. L., Torres, Y. C., Gardino, N. D., Dieffenbach, J. R., & Gabrieli, J. (2021). Implementing Remote Developmental Research: A Case Study of an RCT Language Intervention During COVID-19. PsyArXiv. https://doi.org/10.31234/osf.io/k9632
-
- Apr 2022
-
docdrop.org docdrop.org
-
When teams of educators believe they have the ability to make a difference, exciting things can happen in a school.
We could read this together as a group, and do some thinking prior to the discussion, or at least even read what other people are thinking.
-
-
twitter.com twitter.com
-
James Ward on Twitter. (n.d.). Twitter. Retrieved April 21, 2022, from https://twitter.com/JamesWard73/status/1470680953643319305
-
-
www.covid-datascience.com www.covid-datascience.com
-
Morris, J. (2021, August 17). Israeli data: How can efficacy vs. severe disease be strong when 60% of hospitalized are vaccinated? Covid Data Science. https://www.covid-datascience.com/post/israeli-data-how-can-efficacy-vs-severe-disease-be-strong-when-60-of-hospitalized-are-vaccinated
Tags
- lang:en
- severe disease
- effective
- dose
- is:blog
- age
- delta
- Pfizer
- risk
- efficacy
- hospitalization
- asymptomatic
- surge
- symptomatic
- vaccine
- variant
- COVID-19
Annotators
URL
-
-
twitter.com twitter.com
-
Carl T. Bergstrom. (2021, August 18). 1. There has been lots of talk about recent data from Israel that seem to suggest a decline in vaccine efficacy against severe disease due to Delta, waning protection, or both. This may have even been a motivation for Biden’s announcement that the US would be adopting boosters. [Tweet]. @CT_Bergstrom. https://twitter.com/CT_Bergstrom/status/1427767356600688646
-
-
twitter.com twitter.com
-
Hilda Bastian, PhD. (2021, February 6). Unofficial unnamed AstraZeneca insider says they are doing the interim analysis for the US trial of the Oxford vaccine. AstraZeneca spokesperson says 4-6 weeks till data release. Https://t.co/VUHgbHN02d One is wrong? Or they’ll release only when have FDA minimum follow-up? Https://t.co/LgjfX8AIti [Tweet]. @hildabast. https://twitter.com/hildabast/status/1357862227106095105
-
-
twitter.com twitter.com
-
Dr Ellie Murray, ScD. (2021, July 6). Also, see👇🏼 [Tweet]. @EpiEllie. https://twitter.com/EpiEllie/status/1412249702460968967
-
-
twitter.com twitter.com
-
(((Howard Forman))). (2021, June 28). There are few more compelling graphics to demonstrate how effective vaccines are: 80+% reduction in hospital admissions for the group most vaccinated. <40% reduction in admissions for the group least likely to be vaccinated. [Tweet]. @thehowie. https://twitter.com/thehowie/status/1409492774009847810
-
-
twitter.com twitter.com
-
Prof. Christina Pagel. (2021, May 23). LONG THREAD on B.1.617.2 & latest PHE data covering: 1) latest tech report on B.1.617.2 (aka ‘India’ variant) 2) vaccine efficacy against B.1.617.2 3) consequences for roadmap 4) avoidability... Or not. [Tweet]. @chrischirp. https://twitter.com/chrischirp/status/1396574267349872644
-
-
twitter.com twitter.com
-
Marc Lipsitch. (2021, July 20). At the risk of boiling down too much and certainly losing some detail, one way to summarize this wonderful thread is that when we think about vaccine effectiveness, we should think of 4 key variables: 1 which vaccine, 2 age of the person, 3 how long after vax, 4 vs what outcome. [Tweet]. @mlipsitch. https://twitter.com/mlipsitch/status/1417595538632060931
-
-
www.abc.net.au www.abc.net.au
-
Just 1 per cent of eligible Canberrans are unvaccinated as the capital becomes one of world’s most-vaccinated cities. (2021, December 30). ABC News. https://www.abc.net.au/news/2021-12-31/covid-canberras-unvaccinated-1-per-cent-in-a-highly-vaxxed-city/100642468
-
-
twitter.com twitter.com
-
CDC. (2022, February 4). A new @CDCMMWR study shows that people who reported always wearing masks or respirators in indoor public settings in California were less likely to test positive for #COVID19 compared with those who reported not wearing a face covering. Learn more. Http://bit.ly/MMWR7106 https://t.co/6UJ9cs60NK [Tweet]. @CDCgov. https://twitter.com/CDCgov/status/1489675180242870278
-
-
twitter.com twitter.com
-
ReconfigBehSci. (2021, July 19). this is how the failure to understand what efficacy means and how it relates to outcomes will be seized on over and over again. Cookie cutter fallacies require cookie cutter clarification by machine tools to be combatted effectively (at least at current levels of moderation) [Tweet]. @SciBeh. https://twitter.com/SciBeh/status/1417164191664730112
-
- Mar 2022
-
twitter.com twitter.com
-
Eran Segal. (2021, August 17). Israel data showing the decay of vaccine efficacy over time. Y-axis is cases per 1000 from July 7 to Aug 10, for unvaccinated, and for people vaccinated at different times Cases are higher in those vaxed earlier Despite world-data caveats, this seems quite compelling https://t.co/5aNz48AC8F [Tweet]. @segal_eran. https://twitter.com/segal_eran/status/1427696623988117505
-
-
www.cnn.com www.cnn.com
-
CNN, A. S. (n.d.). Pfizer begins Phase 2 and 3 trial of Covid-19 antiviral Paxlovid in children ages 6 to 17. CNN. Retrieved 22 March 2022, from https://www.cnn.com/2022/03/09/health/pfizer-paxlovid-pediatric-trial/index.html
-
-
www.theguardian.com www.theguardian.com
-
Yang, M. (2022, February 28). Pfizer vaccine significantly less effective in children ages five to 11, study shows. The Guardian. https://www.theguardian.com/society/2022/feb/28/pfizer-vaccine-less-effective-children-ages-five-to-11-data
-
-
www.bmj.com www.bmj.com
-
Mahase, E. (2022). Covid-19: Sanofi and GSK to seek regulatory authorisation for protein based vaccine. BMJ, 376, o526. https://doi.org/10.1136/bmj.o526
-
- Feb 2022
-
-
Mancini, D. P., & Smyth, J. (2022, February 16). Merck struggles to win European approval for Covid-19 antiviral pill. Financial Times. https://www.ft.com/content/2cf0b6cc-b07b-4ff9-a833-42eb1798a576
-
-
assets.publishing.service.gov.uk assets.publishing.service.gov.uk
-
Academics: Viral Evolution Scenarios, 10 February 2022. (n.d.). GOV.UK. Retrieved February 14, 2022, from https://www.gov.uk/government/publications/academics-viral-evolution-scenarios-10-february-2022
Tags
- lang:en
- is:report
- protection
- waning immunity
- viral evolution
- immune escape
- transmissibility
- UK
- therapeutic
- severity
- scenario
- testing
- antigenic escape
- vaccination
- prediction
- vaccine
- antiviral drug resistance
- variant
- heterogeneity
- surveillance
- infection
- vaccine efficacy
- COVID-19
- immunity
Annotators
URL
-
-
-
Mahase, E. (2022). Covid-19: What do we know about omicron sublineages? BMJ, 376, o358. https://doi.org/10.1136/bmj.o358
-
-
www.youtube.com www.youtube.com
-
American Medical Association (AMA). (2021, December 6). Peter Hotez, MD, PhD, on the omicron variant and Delta winter surge | COVID-19 Update for Dec. 6, 20. https://www.youtube.com/watch?v=WnfpC1_N2Mg
-
-
www.ncbi.nlm.nih.gov www.ncbi.nlm.nih.gov
-
Afkhami, S., D’Agostino, M. R., Zhang, A., Stacey, H. D., Marzok, A., Kang, A., Singh, R., Bavananthasivam, J., Ye, G., Luo, X., Wang, F., Ang, J. C., Zganiacz, A., Sankar, U., Kazhdan, N., Koenig, J. F. E., Phelps, A., Gameiro, S. F., Tang, S., … Xing, Z. (2022). Respiratory mucosal delivery of next-generation COVID-19 vaccine provides robust protection against both ancestral and variant strains of SARS-CoV-2. Cell, S0092867422001453. https://doi.org/10.1016/j.cell.2022.02.005
-
-
www.sciencedirect.com www.sciencedirect.com
-
Chatterjee, D., Tauzin, A., Marchitto, L., Gong, S. Y., Boutin, M., Bourassa, C., Beaudoin-Bussières, G., Bo, Y., Ding, S., Laumaea, A., Vézina, D., Perreault, J., Gokool, L., Morrisseau, C., Arlotto, P., Fournier, É., Guilbault, A., Delisle, B., Levade, I., … Finzi, A. (2022). SARS-CoV-2 Omicron Spike recognition by plasma from individuals receiving BNT162b2 mRNA vaccination with a 16-weeks interval between doses. Cell Reports, 0(0). https://doi.org/10.1016/j.celrep.2022.110429
-
-
twitter.com twitter.com
-
PaedsHaemDoc. (2022, January 9). Had the misfortune (via @fatemperor) to come across Dr Paul Alexander -apparently credentialed yet in single blog post demonstrates perfectly either a disconnect from rational thought or deliberate misinformation spreading of the #masspsychosis of the anti-Vax crew let’s examine https://t.co/Ctd49cb1qK [Tweet]. @dr_barrett. https://twitter.com/dr_barrett/status/1479986071832248322
-
-
www.bmj.com www.bmj.com
-
Mahase, E. (2022). Omicron sub-lineage BA.2 may have “substantial growth advantage,” UKHSA reports. BMJ, 376, o263. https://doi.org/10.1136/bmj.o263
-
-
www.theguardian.com www.theguardian.com
-
Devlin, H., & correspondent, H. D. S. (2022, February 3). Novavax Covid vaccine approved for use in over-18s in UK. The Guardian. https://www.theguardian.com/society/2022/feb/03/novavax-covid-vaccine-approved-for-use-in-over-18s-in-uk
-
- Jan 2022
-
twitter.com twitter.com
-
ReconfigBehSci on Twitter: “RT @AliHMokdad: Vaccine effectiveness against BA.1 and BA.2. After 2 doses it was 9% (7-10%) and 13% (-26-40%) respectively for BA.1 and BA…” / Twitter. (n.d.). Retrieved January 30, 2022, from https://twitter.com/SciBeh/status/1487123660771106821
-
-
eductive.ca eductive.ca
-
Depuis longtemps, je suis d’avis que la rigueur d’un cours ne se mesure pas à la quantité de connaissances dont l’enseignant fait étalage, mais aux apprentissages que les étudiants font.
Which can lead to an assessment of pedagogical efficacy. It's funny, to me, that those who complain about "grade inflation" (typically admins) rarely entertain the notion that grades could be higher than usual if the course went well. The situation is quite different in "L&D" (Learning and Development, typically for training and professional development in an organizational context). "Oh, great! We were able to get everyone to reach the standard for this competency! Must mean that we've done something right in our Instructional Design!"
-
-
www.theguardian.com www.theguardian.com
-
Yang, M. (2022, January 14). ‘Menace to public health’: 270 doctors criticize Spotify over Joe Rogan’s podcast. The Guardian. https://www.theguardian.com/technology/2022/jan/14/spotify-joe-rogan-podcast-open-letter
-
-
www.theguardian.com www.theguardian.com
-
Augustin, E. (2022, January 5). Cuba’s vaccine success story sails past mark set by rich world’s Covid efforts. The Guardian. https://www.theguardian.com/world/2022/jan/05/cuba-coronavirus-covid-vaccines-success-story
-
-
twitter.com twitter.com
-
Allyson Pollock. (2022, January 2). I am told that masks obey the law of physics! How does theory translate into practice? How often do you touch mask, wash it, shove it in your pocket? If you sneeze/cough do you a) take mask off, use a handkerchief, wash hands b) keep mask on -if so where does the snot go? [Tweet]. @AllysonPollock. https://twitter.com/AllysonPollock/status/1477737957054365696
-
- Dec 2021
-
calgaryherald.com calgaryherald.com
-
Calgary Herald. (n.d.). Calgaryherald. Retrieved December 21, 2021, from https://calgaryherald.com/news/local-news/anti-covid-vaccine-dad-loses-battle-with-ex-wife-over-whether-to-get-their-children-inoculated
-
-
vancouversun.com vancouversun.com
-
227 B.C. chiropractors threaten to sue regulatory college if vaccines ordered. (n.d.). Vancouversun. Retrieved December 17, 2021, from https://vancouversun.com/news/local-news/227-b-c-chiropractors-threaten-to-sue-regulatory-college-if-vaccines-ordered
-
-
healthydebate.ca healthydebate.ca
-
Vaccination among the pregnant lagging despite growing evidence of safety and efficacy. (2021, December 10). Healthy Debate. https://healthydebate.ca/2021/12/topic/vaccination-pregnant-safe-efficacy/
-
-
www.science.org www.science.org
-
‘It’s misinformation at worst.’ Weak health studies can do more harm than good, scientists say. (n.d.). Retrieved December 13, 2021, from https://www.science.org/content/article/it-s-misinformation-worst-weak-health-studies-can-do-more-harm-good-scientists-say
-
-
www.thelancet.com www.thelancet.com
-
Ortiz, J. R., & Neuzil, K. M. (2021). The value of vaccine programme impact monitoring during the COVID-19 pandemic. The Lancet, 0(0). https://doi.org/10.1016/S0140-6736(21)02322-9
-
-
thl.fi thl.fi
-
THL recommends coronavirus vaccinations for at-risk children aged 5 to 11 years, for the entire age group require more information on safety—Press release—THL. (n.d.). Finnish Institute for Health and Welfare (THL), Finland. Retrieved December 6, 2021, from https://thl.fi/en/web/thlfi-en/-/thl-recommends-coronavirus-vaccinations-for-at-risk-children-aged-5-to-11-years-for-the-entire-age-group-require-more-information-on-safety?redirect=%2Fen%2Fweb%2Fthlfi-en%2Fwhats-new
-
-
www.theguardian.com www.theguardian.com
-
Sridhar, D. (2021, November 28). How bad will the Omicron Covid variant be in Britain? Three things will tell us. The Guardian. https://www.theguardian.com/commentisfree/2021/nov/28/omicron-covid-variant-britain-southern-africa
Tags
- lang:en
- protection
- travel restrictions
- health outcome
- data
- travel ban
- UK
- transmission
- Omicron
- England
- predominant strain
- stock market
- home-testing kit
- hospitalization
- government
- is:news
- testing
- mask wearing
- strategy
- mask mandate
- virus genome
- vaccine
- public health measures
- variant
- vaccine efficacy
- booster
- mortality
- COVID-19
- South Africa
- immunity
- science
Annotators
URL
-
-
www.statnews.com www.statnews.com
-
Cause for optimism on Omicron: Our immune systems aren’t blank slates. (2021, December 1). STAT. https://www.statnews.com/2021/12/01/a-reason-for-optimism-on-omicron-our-immune-systems-are-not-blank-slates/
Tags
- lang:en
- protection
- mutation
- immunology
- vaccine
- previous infection
- Omicron
- variant
- vaccine efficacy
- immune response
- COVID-19
- immunity
- is:news
Annotators
URL
-
-
news.sky.com news.sky.com
-
COVID-19: Most Omicron cases are “mild” and there’s no evidence to suggest vaccines may be less effective against the variant, says WHO official. (n.d.). Sky News. Retrieved December 2, 2021, from https://news.sky.com/story/covid-19-most-omicron-cases-are-mild-and-theres-no-evidence-to-suggest-vaccines-may-be-less-effective-against-the-variant-says-who-12483729
-
-
www.washingtonpost.com www.washingtonpost.com
-
FDA authorizes Pfizer-BioNTech, Moderna boosters for all adults. (2021). Washington Post. Retrieved November 22, 2021, from https://www.washingtonpost.com/health/2021/11/19/fda-clears-pfizer-biontech-moderna-booster-shots-all-adults/
-
-
assets.publishing.service.gov.uk assets.publishing.service.gov.uk
-
COVID-19 vaccine surveillance report—Week 47. (n.d.). 46.
Tags
- lang:en
- is:report
- clinical trials
- protection
- research
- data
- UK
- safety profile
- UKHSA
- vaccine
- delta
- approval
- vaccine efficacy
- immune response
- COVID-19
Annotators
URL
-
- Nov 2021
-
www.thelancet.com www.thelancet.com
-
Wheatley, A. K., & Juno, J. A. (2021). COVID-19 vaccines in the age of the delta variant. The Lancet Infectious Diseases, 0(0). https://doi.org/10.1016/S1473-3099(21)00688-5
-
-
www.nature.com www.nature.com
-
Reardon, S. (2021). Cuba’s bet on home-grown COVID vaccines is paying off. Nature. https://doi.org/10.1038/d41586-021-03470-x
-
-
-
Covid: US approves Pfizer vaccine for children over five. (2021, November 3). BBC News. https://www.bbc.com/news/world-us-canada-59044853
-
-
www.nejm.org www.nejm.org
-
Walter, E. B., Talaat, K. R., Sabharwal, C., Gurtman, A., Lockhart, S., Paulsen, G. C., Barnett, E. D., Muñoz, F. M., Maldonado, Y., Pahud, B. A., Domachowske, J. B., Simões, E. A. F., Sarwar, U. N., Kitchin, N., Cunliffe, L., Rojo, P., Kuchar, E., Rämet, M., Munjal, I., … Gruber, W. C. (2021). Evaluation of the BNT162b2 Covid-19 Vaccine in Children 5 to 11 Years of Age. New England Journal of Medicine, NEJMoa2116298. https://doi.org/10.1056/NEJMoa2116298
-
-
www.theguardian.com www.theguardian.com
-
Otte, J. (2021, November 11). ‘No jab, no job’: Care home workers in England on the Covid vaccine mandate. The Guardian. https://www.theguardian.com/society/2021/nov/11/england-care-home-workers-on-mandatory-covid-vaccines
-
-
journals.sagepub.com journals.sagepub.com
-
Gurdasani, D., Bhatt, S., Costello, A., Denaxas, S., Flaxman, S., Greenhalgh, T., Griffin, S., Hyde, Z., Katzourakis, A., McKee, M., Michie, S., Ratmann, O., Reicher, S., Scally, G., Tomlinson, C., Yates, C., Ziauddeen, H., & Pagel, C. (2021). Vaccinating adolescents against SARS-CoV-2 in England: A risk–benefit analysis. Journal of the Royal Society of Medicine, 01410768211052589. https://doi.org/10.1177/01410768211052589
-
-
twitter.com twitter.com
-
Prof Peter Hotez MD PhD. (2021, October 30). Many thanks @FWhitfield for hosting me this Saturday AM @CNN In case it’s helpful, I’ve prepared an informal ‘fact sheet’ on COVID in children and COVID vaccines in 5-11 age group. Highlights attached...feel free to RT or repurpose the information [Tweet]. @PeterHotez. https://twitter.com/PeterHotez/status/1454489603013062656
-
- Oct 2021
-
pubmed.ncbi.nlm.nih.gov pubmed.ncbi.nlm.nih.gov
-
Kennedy-Shaffer, L., Kahn, R., & Lipsitch, M. (2021). Estimating Vaccine Efficacy Against Transmission via Effect on Viral Load. Epidemiology (Cambridge, Mass.), 32(6), 820–828. https://doi.org/10.1097/EDE.0000000000001415
-
-
www.medrxiv.org www.medrxiv.org
-
Follmann, D., & Fay, M. (2021). Vaccine Efficacy at a Point in Time (p. 2021.02.04.21251133). https://doi.org/10.1101/2021.02.04.21251133
-
-
www.cebm.net www.cebm.net
-
Measuring vaccine efficacy from population data. (n.d.). The Centre for Evidence-Based Medicine. Retrieved 29 October 2021, from https://www.cebm.net/covid-19/measuring-vaccine-efficacy-from-population-data/
-
-
conscienhealth.org conscienhealth.org
-
For Teens with Obesity, COVID Vaccines Save Lives. (2021, October 21). ConscienHealth. https://conscienhealth.org/2021/10/for-teens-with-obesity-covid-vaccines-save-lives/
-
-
www.biorxiv.org www.biorxiv.org
-
Rono, E. K. (2021). Covid-19 genomic analysis reveals clusters of emerging sublineages within the delta variant [Preprint]. Genomics. https://doi.org/10.1101/2021.10.08.463334
-
-
-
Mlcochova, P., Kemp, S. A., Dhar, M. S., Papa, G., Meng, B., Ferreira, I. A. T. M., Datir, R., Collier, D. A., Albecka, A., Singh, S., Pandey, R., Brown, J., Zhou, J., Goonawardane, N., Mishra, S., Whittaker, C., Mellan, T., Marwal, R., Datta, M., … Gupta, R. K. (2021). SARS-CoV-2 B.1.617.2 Delta variant replication and immune evasion. Nature, 1–6. https://doi.org/10.1038/s41586-021-03944-y
-
-
twitter.com twitter.com
-
Hilda Bastian, PhD on Twitter. (n.d.). Twitter. Retrieved 10 October 2021, from https://twitter.com/hildabast/status/1440714908924923904
-
-
www.theguardian.com www.theguardian.com
-
‘A bit of a mystery’: Why hospital admissions for Covid in England are going down | Coronavirus | The Guardian. (n.d.). Retrieved 8 October 2021, from https://www.theguardian.com/world/2021/sep/24/a-bit-of-a-mistery-why-england-covid-cases-are-going-down-despite-ease-of-restrictions
-
-
www.cloverbiopharma.com www.cloverbiopharma.com
-
Clover’s COVID-19 Vaccine Candidate Demonstrates 79% Efficacy Against Delta in Global Phase 2/3 SPECTRA Trial Dominated by Variants of Concern and Interest—Clover Biopharmaceuticals. (n.d.). Retrieved 4 October 2021, from https://www.cloverbiopharma.com/news/83.html
-
-
www.frontiersin.org www.frontiersin.org
-
Palm, R., Bolsen, T., & Kingsland, J. T. (2021). The Effect of Frames on COVID-19 Vaccine Resistance. Frontiers in Political Science, 3, 661257. https://doi.org/10.3389/fpos.2021.661257
-
-
www.sciencemag.org www.sciencemag.org
-
Kupferschmidt, K., VogelMar. 27, G., 2021, & Am, 10:20. (2021, March 27). A rare clotting disorder may cloud the world’s hopes for AstraZeneca’s COVID-19 vaccine. Science | AAAS. https://www.sciencemag.org/news/2021/03/rare-clotting-disorder-may-cloud-worlds-hopes-astrazenecas-covid-19-vaccine
-
-
www.thelancet.com www.thelancet.com
-
Emary, K. R. W., Golubchik, T., Aley, P. K., Ariani, C. V., Angus, B., Bibi, S., Blane, B., Bonsall, D., Cicconi, P., Charlton, S., Clutterbuck, E. A., Collins, A. M., Cox, T., Darton, T. C., Dold, C., Douglas, A. D., Duncan, C. J. A., Ewer, K. J., Flaxman, A. L., … Pollard, A. J. (2021). Efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine against SARS-CoV-2 variant of concern 202012/01 (B.1.1.7): an exploratory analysis of a randomised controlled trial. The Lancet, 0(0). https://doi.org/10.1016/S0140-6736(21)00628-0
https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(21)00628-0/fulltext
-
-
www.theatlantic.com www.theatlantic.com
-
Bastian, H. (2021, June 24). The mRNA Vaccines Are Extraordinary, but Novavax Is Even Better. The Atlantic. https://www.theatlantic.com/health/archive/2021/06/novavax-now-best-covid-19-vaccine/619276/
-
-
www.nejm.org www.nejm.org
-
Covid-19 Vaccine Resource Center. (n.d.). Https://Www.Nejm.Org. Retrieved July 19, 2021, from https://www.nejm.org/covid-vaccine
-
-
www.medrxiv.org www.medrxiv.org
-
Higdon, M. M., Wahl, B., Jones, C. B., Rosen, J. G., Truelove, S. A., Baidya, A., Nande, A. A., ShamaeiZadeh, P. A., Walter, K. K., Feikin, D. R., Patel, M. K., Knoll, M. D., & Hill, A. L. (2021). A systematic review of COVID-19 vaccine efficacy and effectiveness against SARS-CoV-2 infection and disease [Preprint]. Epidemiology. https://doi.org/10.1101/2021.09.17.21263549
-
- Sep 2021
-
psyarxiv.com psyarxiv.com
-
Milfont, T. L., Osborne, D., & Sibley, C. G. (2021). Political efficacy explains increase in New Zealanders’ pro-environmental attitudes due to COVID-19. PsyArXiv. https://doi.org/10.31234/osf.io/m7w9y
-
-
twitter.com twitter.com
-
John Burn-Murdoch. (2021, August 23). NEW: in the last couple of weeks there have a lot of new studies out assessing vaccine efficacy, many of which have touched on the question of waning immunity. Unsurprisingly, these have prompted a lot of questions. Time for a thread to summarise what we do and don’t know: [Tweet]. @jburnmurdoch. https://twitter.com/jburnmurdoch/status/1429878189011111936
-
-
twitter.com twitter.com
-
Hannah Davis 🌈 on Twitter: “New CDC study finds that 36% of COVID patients never seroconvert, meaning they NEVER make antibodies! #LongCovid This is a huge finding which we need to amplify broadly! Please retweet & send to providers, patients, support groups, #MedTwitter, etc. Https://t.co/gEne4dE0TQ 1/” / Twitter. (n.d.). Retrieved September 1, 2021, from https://twitter.com/ahandvanish/status/1432411002688184320?s=20
-
- Aug 2021
-
twitter.com twitter.com
-
Tim Plante, MD MHS on Twitter: “Just reported: About half of recent ICU patients with #Covid19 in #Vermont are vaccinated. Sounds like the vaccines aren’t working, right? WRONG. Vaccines are working and here’s why. But first, let’s talk a bit about unprotected sex. A thread. (Refs at the end.) 1/n https://t.co/iyQcfCDAfh” / Twitter. (n.d.). Retrieved August 27, 2021, from https://twitter.com/tbplante/status/1430222978961317896
-
-
www.biorxiv.org www.biorxiv.org
-
Liu, Y., Arase, N., Kishikawa, J., Hirose, M., Li, S., Tada, A., Matsuoka, S., Arakawa, A., Akamatsu, K., Ono, C., Jin, H., Kishida, K., Nakai, W., Kohyama, M., Nakagawa, A., Yamagishi, Y., Nakagami, H., Kumanogoh, A., Matsuura, Y., … Arase, H. (2021). The SARS-CoV-2 Delta variant is poised to acquire complete resistance to wild-type spike vaccines (p. 2021.08.22.457114). https://doi.org/10.1101/2021.08.22.457114
-
-
twitter.com twitter.com
-
(2) David Fisman on Twitter: “Here’s some really simple modeling that hopefully will help provide some insight into why having a large, unvaccinated minority in Ontario is a problem for the population as a whole.” / Twitter. (n.d.). Retrieved August 23, 2021, from https://twitter.com/DFisman/status/1427940663925092354
-
-
twitter.com twitter.com
-
(2) Dr Nicole E Basta on Twitter: “There is SO MUCH misunderstanding about what a #vaccine #mandate IS & what a vaccine mandate DOES. No one is calling for anyone to be banned. No one is calling for anyone to be forcibly vaccinated. Please, gather 'round and listen up, so you know what we’re talking about... 1/n” / Twitter. (n.d.). Retrieved August 23, 2021, from https://twitter.com/IDEpiPhD/status/1428410251884302336?s=20
-
-
-
Mahase, E. (2021). Covid-19: How many variants are there, and what do we know about them?: Video 1. BMJ, n1971. https://doi.org/10.1136/bmj.n1971
-